On September 9, 2020 Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostics designed to provide physicians with clinically actionable information to improve the patient outcomes, reported that President and CEO Michael Nall will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Monday, September 14, 2020 at 3:30 p.m. Eastern time (12:30 p.m. Pacific time) (Press release, Biocept, SEP 9, 2020, View Source [SID1234564894]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live presentation can be accessed here and will be archived on the Investor Relations section of the Biocept website.

On September 9, 2020 Viracta Therapeutics, Inc. (the "Company"), a precision oncology company targeting virus-associated malignancies, reported that Ivor Royston, MD, President and Chief Executive Officer of Viracta, will present a corporate overview at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 3:00 pm ET (Press release, Viracta Therapeutics, SEP 9, 2020, https://www.prnewswire.com/news-releases/viracta-therapeutics-to-present-at-the-hc-wainwright-22nd-annual-global-investment-conference-301125916.html [SID1234564892]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On September 9, 2020 Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, reported that it will be featured as a presenting company at the 22nd Annual Global Investment Conference sponsored by H.C Wainwright (Press release, Arcadia Biosciences, SEP 9, 2020, https://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-to-present-at-hc-wainwrights-22nd-annual-global-investment-conference-september-14-16-2020-301126240.html [SID1234564890]). The conference is being held virtually on September 14-16, 2020.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Matthew Plavan, Arcadia’s president and CEO will present a business overview at 2:00 p.m. EDT on Wednesday, September 16, 2020 and will be available for one-on-one web meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hccwevents.com.

The presentation will be webcast live here, and a replay will be available in the Investors section of the company’s website.

On September 9, 2020 Rigel Pharmaceuticals (Nasdaq: RIGL) reported that Dean Schorno, the company’s chief financial officer, is scheduled to present a company overview at two virtual investor conferences in September (Press release, Rigel, SEP 9, 2020, View Source [SID1234564889]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investor Presentations:
H.C. Wainwright 22nd Annual Global Investment Conference
Date: Tuesday, September 15, 2020
Time: 1:00pm ET/10:00am PT

Cantor Fitzgerald Virtual Global Healthcare Conference 2020
Date: Wednesday, September 16, 2020
Time: 1:20pm ET/10:20am PT

To access these events live or the archived webcasts, go to the Investors section of the company’s website at www.rigel.com. Please connect to Rigel’s website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

On September 9, 2020 Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN.TA), reported it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference (Press release, Biomica, SEP 9, 2020, https://www.prnewswire.com/news-releases/biomica-announces-participation-at-the-hc-wainwright-22nd-annual-global-investment-conference-on-september-14-16-2020-virtual-conference-301126264.html [SID1234564887]). The conference is being held on September 14-16, 2020 virtually.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Elran Haber, CEO of Biomica, will provide an overview of the Company’s business during a live presentation, scheduled for Wednesday, September 16, 12:30 PM (EDT), and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.hcwevents.com ) to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.